The title of Torjesen’s article, “BMA should drop its opposition to assisting dying, say members in landmark poll,”1 […]
ABSTRACTOvarian cancer is the third most common gynecologic malignancy worldwide but accounts for the highest mortality rate among […]
New approval marks third indication for an Opdivo plus Yervoy-based regimen in the EU
Industry bodies respond to Specialised Committee outcome
Approval is based on results from phase III THALES trial
Conclusions made by a group of experts from academia and industry
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT
Updated Date: Fri, 30 Oct 2020 00:00:00 EDT